Real-world Primary Treatment Patterns in Stages I-III Non-Small Cell Lung Cancer

被引：0
作者：
Donington, J. S. [1 ]
Hu, X. [2 ]
Zhang, S. [2 ]
Gao, C. [2 ]
Arunachalam, A. [2 ]
Chirovsky, D. [2 ]
Lerner, A. [2 ]
Jiang, A. [2 ]
Signorovitch, J. [2 ]
Samkari, A. [2 ]
机构：
[1] Univ Chicago, Chicago, IL USA
[2] Merck & Co Inc, Rahway, NJ USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
surgery; adjuvant therapy; neoadjuvant therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.25-06
引用
收藏
页码：S270 / S271
页数：2
相关论文
共 50 条
  • [41] Treatment of stage I non-small cell lung cancer: What's trending?
    McMurry, Timothy L.
    Shah, Puja M.
    Samson, Pamela
    Robinson, Clifford G.
    Kozower, Benjamin D.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (03) : 1080 - 1087
  • [42] Is surgery still the optimal treatment for stage I non-small cell lung cancer?
    Moghanaki, Drew
    Chang, Joe Y.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (02) : 183 - 189
  • [43] Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer
    Onishi, Hiroshi
    Shioyama, Yoshiyuki
    Matsumoto, Yasuo
    Matsuo, Yukinori
    Miyakawa, Akifumi
    Yamashita, Hideomi
    Matsushita, Haruo
    Aoki, Masahiko
    Nihei, Keiji
    Kimura, Tomoki
    Ishiyama, Hiromichi
    Murakami, Naoya
    Nakata, Kensei
    Takeda, Atsuya
    Uno, Takashi
    Nomiya, Takuma
    Taguchi, Hiroshi
    Seo, Yuji
    Komiyama, Takafumi
    Marino, Kan
    Aoki, Shinichi
    Matsuda, Masaki
    Akita, Tomoko
    Saito, Masahide
    CANCERS, 2023, 15 (17)
  • [44] Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study
    Gao, Yang
    Jiang, Juan
    Xiao, Desheng
    Zhou, Yanwu
    Chen, Yufan
    Yang, Huaping
    Wang, Lijing
    Zeng, Jun
    He, Baimei
    He, Ruoxi
    Li, Min
    Liu, Zhaoqian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Treatment patterns and clinical outcomes of resectable central non-small cell lung cancer patients undergoing sleeve lobectomy: a large-scale, single-center, real-world study
    Han, Rui
    Zhang, Fan
    Zhan, Chang
    Hong, Qian
    Zhao, Chenguang
    Djaferi, Visar
    Wang, Fuquan
    Qi, Pengfei
    Muhammad, Shan
    Li, Fang
    Li, Jiagen
    Mu, Juwei
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (11) : 3050 - 3066
  • [46] Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study
    Li, Jialong
    Wang, Youyu
    Zhao, Zerui
    Wang, Sihua
    Yan, Wanpu
    Chen, Xiaohui
    Chen, Tianxiang
    Li, Pengfei
    Wang, Sheng
    Fang, Qiang
    Peng, Lin
    Han, Yongtao
    Tang, Jian
    Leng, Xuefeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (12) : 3344 - 3351
  • [47] Neoadjuvant Chemoradiotherapy for Stage iii Non-Small Cell Lung Cancer
    Sher, David J.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [48] Treatment of stage IIIA non-small cell lung cancer
    Robinson, LA
    Wagner, H
    Ruckdeschel, JC
    CHEST, 2003, 123 (01) : 202S - 220S
  • [49] Surgical treatment of oligometastatic non-small cell lung cancer
    Pfannschmidt, Joachim
    Dienemann, Hendrik
    LUNG CANCER, 2010, 69 (03) : 251 - 258
  • [50] Treatment of stage II non-small cell lung cancer
    Scott, WJ
    Howington, J
    Movsas, B
    CHEST, 2003, 123 (01) : 188S - 201S
12345